EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY

被引：0
|
作者：
Saliba, F. [1 ]
Duvoux, C. [2 ]
Durand, F. [3 ]
Neau-Cransac, M. [4 ]
Hardwigsen, J. [5 ]
Pageaux, G. [6 ]
Di Giambattista, F. [7 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] Hop Henri Mondor, F-94010 Creteil, France
[3] Hop Beaujon, Clichy, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Conception, Marseille, France
[6] Hop St Eloi, Montpellier, France
[7] Novartis Pharma SAS, Rueil Malmaison, France
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
74
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
  • [2] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
  • [3] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [4] Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12-and 36-month results
    Levy, Gary
    Schmidli, Heinz
    Punch, Jeffrey
    Tuttle-Newhall, Elizabeth
    Mayer, David
    Neuhaus, Peter
    Samuel, Didier
    Nashan, Bjorn
    Klempnauer, Juergen
    Langnas, Alan
    Calmus, Yvon
    Rogiers, Xavier
    Abecassis, Michael
    Freeman, Richard
    Sloof, Maarten
    Roberts, John
    Fischer, Lutz
    LIVER TRANSPLANTATION, 2006, 12 (11) : 1640 - +
  • [5] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [6] mTOR Inhibitor Attributed Adverse Events: Results from the H2304 Study Comparing Everolimus and Tacrolimus in De Novo Liver Transplant Recipients
    Fischer, L.
    De Simone, P.
    Fung, J.
    Nevens, F.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Chavin, K.
    Chapman, W. C.
    Jiang, H.
    Lopez, P.
    Junge, G.
    De Carlis, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 126 - 126
  • [7] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.
    De Simone, P.
    Kaiser, G. M.
    De Carlis, L.
    Metselaar, H. J.
    Duvoux, C.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    Saliba, F.
    LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
  • [8] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
    Duvoux, C.
    Saliba, F.
    Kaiser, G.
    De Carlis, L.
    Metselaar, H.
    De Simone, P.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 710 - 710
  • [9] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
    Duvoux, C.
    Saliba, F.
    Kaiser, G.
    De Carlis, L.
    Metselaar, H.
    De Simone, P.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
  • [10] mTOR Inhibition and Hepatic Artery Thrombosis in de Novo Liver Transplant Recipients - Mitigation Strategy with Everolimus: 12 Month Results from Study H2304
    Jonas, S.
    Chapman, W.
    McCormack, L.
    Burroughs, Gordon S.
    Alsina, A.
    Junge, G.
    Witte, S.
    Hexham, J. M.
    Fischer, L.
    TRANSPLANTATION, 2012, 94 (10) : 132 - 132
12345